The Verso awarded a 7A ODEP rating

Mar 2, 2023
Innovative Design Orthopaedics (IDO) is proud to announce that the VERSO® shoulder joint replacement has recently been awarded by the Orthopaedic Data Evaluation Panel (ODEP) in the UK a 7A ODEP Rating.

The 7A ODEP rating of the Verso® Reverse Shoulder replacement with uncemented Metaphyseal fixation (Metal short Metaphyseal Shells combinations/ Metal Baseplate / Glenospheres and Polyethylene Liners) has been approved at the latest ODEP shoulder meeting published in late January 2023.

Shoulder ratings are provided at benchmarks of 3, 5, 7 and 10 years of follow-up alongside an ‘A’ or ‘B’ rating dependent upon the strength of evidence and quality of the data provided. ODEP ratings provide a simple, independently verified assessment of the performance of an implant, assessed against clinical best practice guidelines. (ODEP ratings can be found on odep.org.uk).

Innovative Design Orthopaedics is proud to remark that the VERSO® has been used in the UK health system since 2014 and it has also been successfully distributed and implanted in other major international markets including Germany, France, Italy, Spain, Poland, Australia, Israel, Greece, S. Africa and others.
The Verso® is currently the only Reverse Shoulder Replacement system with short metaphyseal (stemless) fixation to attain a 7A ODEP rating. This achievement, together with the increased awareness of the system and its acceptance by leading surgeons around the world, acknowledges the outstanding clinical results that the system has enjoyed.
The Verso® system was launched on the market in 2005 and was actively marketed from 2014 following its acquisition by Innovative Design Orthopaedics. A Stemmed Reverse version, designed mainly for fractures and revisions is also available from IDO, but due to limited use not yet ripe for ODEP rating.